Page 1 of Clinical Trials for Biological recombinant interferon gamma, 81 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Biological Therapy in Treating Patients With Prostate Cancer
Last Updated: February 6, 2009
Condition(s): Prostate Cancer
2
Recruiting
Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma
Last Updated: April 17, 2012
Condition(s): Melanoma
3
Active, not recruiting
Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
Last Updated: February 6, 2009
Condition(s): Melanoma (Skin)
4
Completed
Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
Last Updated: February 6, 2009
Condition(s): Breast Cancer
5
Completed
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
Last Updated: May 13, 2011
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
6
Recruiting
Autologous T Cells, Low-Dose Recombinant Interferon Gamma, Cyclophosphamide, and Low-Dose Aldesleukin in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery
Last Updated: January 30, 2012
Condition(s): Adult Liposarcoma; Adult Synovial Sarcoma; Recurrent Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma
7
Completed
A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Last Updated: November 2, 2007
Condition(s): Idiopathic Pulmonary Fibrosis
8
Recruiting
A Study of Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)
Last Updated: April 25, 2012
Condition(s): Metastatic Melanoma
9
Completed
Tumor Cell Vaccine in Treating Patients With Advanced Cancer
Last Updated: May 10, 2011
Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
10
Completed
A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
Last Updated: March 3, 2008
Condition(s): Melanoma
11
Completed
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
Last Updated: November 20, 2010
Condition(s): Lymphoma
12
Completed
Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer
Last Updated: February 6, 2009
Condition(s): Ovarian Cancer
13
Active, not recruiting
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
Last Updated: February 6, 2009
Condition(s): Graft Versus Host Disease; Lymphoma
14
Completed
Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
Last Updated: February 6, 2009
Condition(s): Melanoma (Skin); Unspecified Adult Solid Tumor, Protocol Specific
15
Completed
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
Last Updated: May 9, 2009
Condition(s): Infection; Unspecified Adult Solid Tumor, Protocol Specific
16
Completed
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Last Updated: June 11, 2009
Condition(s): Breast Cancer; Colorectal Cancer; Kidney Cancer; Lung Cancer; Malignant Mesothelioma; Pancreatic Cancer
17
Completed
Fluorouracil, Phenylbutyrate, Indomethacin, and Interferon Gamma in Treating Patients With Advanced Colorectal Cancer
Last Updated: February 6, 2009
Condition(s): Colorectal Cancer
18
Completed
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Last Updated: June 4, 2011
Condition(s): Leukemia
19
Completed
Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Last Updated: September 28, 2009
Condition(s): Influenza
20
Completed
ITV Extension Study
Last Updated: February 26, 2007
Condition(s): HIV

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+recombinant+interferon+gamma

Page 1 of Clinical Trials for Biological recombinant interferon gamma, 81 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About